NCT01897987View on ClinicalTrials.gov

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions

Bronchopulmonary Dysplasia

Interventions

BIOLOGICAL

Pneumostem®

BIOLOGICAL

normal saline

Trial Locations (2)

Unknown

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Medipost Co Ltd.

INDUSTRY

NCT01897987 - Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial | Biotech Hunter | Biotech Hunter